Tetrahydrocannabinol as an antiemetic for cancer patients.
D000932:Antiemetics / Q000627:therapeutic use*; D013759:Dronabinol / Q000378:metabolism / Q000627:therapeutic use*; D007700:Kinetics; D009325:Nausea / Q000209:etiology; D009369:Neoplasms / Q000188:drug therapy*; D014839:Vomiting / Q000209:etiology
D000932:Antiemetics; D013759:Dronabinol